header logo image

FDA approves Phase II clinical trial of stem cells for Lou Gehrig’s disease (ALS) – Video

April 19th, 2013 8:45 pm




FDA approves Phase II clinical trial of stem cells for Lou Gehrig #39;s disease (ALS)
Dr. Eva Feldman, U-M neurologist and director of the A. Alfred Taubman Medical Research Institute, discusses the recent FDA approval of a new phase for a cli...

By: UMHealthSystem

More here:
FDA approves Phase II clinical trial of stem cells for Lou Gehrig's disease (ALS) - Video

Comments are closed.


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick